French cosmetic active maker Robertet has unveiled the results of studies into its Damasty ingestible skin care ingredient.
Over 160 women enrolled into four clinical studies into the antioxidant properties of the ingredient, which is derived from the Damask rose (Rosa damascena).
One 300mg capsule of Damasty was found to increase the skin’s natural antioxidant defences in women after only one month of daily consumption.
The results were confirmed by an indirect count conducted in a cohort of 42 women over a period of three months, within a double-blind trial.
A significant reduction was observed in the trial group as compared to the control group.
Robertet said these two placebo-controlled clinical trials demonstrate the mechanism of action through which Damasty consumption allows strengthening the natural defence of the skin and better preparing it to withstand external aggressions.
Another study found that after two months where women daily consumed 300mg (1 capsule) of this novel active ingredient, 100% of subjects indicated their skin was brighter.
The difference in terms of skin evenness also evolved throughout the trial.
The results showed a significant improvement in terms of skin evenness (+45%) between the beginning of the study and the end of the two-month supplementation period with Damasty.
Finally, the melanin index further confirmed these effects.
“This marker diminished significantly more in the women having consumed the tested product starting from the first month as compared to the women in the placebo group,” said a spokeswoman.
“This effect continued to intensify until the third month of consumption, thereby demonstrating the effect of Damasty on skin evenness,” she added.
